There is also evidence that BACE1 is upregulated during aging and AD, thus favoring amyloidogenic APP processing (Fukumoto et al., 2002, 2004; Holsinger et al., 2002; Yang et al., 2003; Li et al., 2004; Ahmed et al., 2010). This evidence concerns the gene BACE1 and Alzheimer disease.